NCT03465501已完成不适用
Interstitial Brachytherapy Boost for Treatment of Anal Canal Cancers, Comparison of Two Dose Rates
Institut Paoli-Calmettes1 个研究点 分布在 1 个国家目标入组 89 人开始时间: 2007年8月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 89
- 试验地点
- 1
- 主要终点
- Evaluation of the efficacy of interstitial brachytherapy of the anal canal
研究概览
简要总结
Comparative retrospective study of two anal canal brachytherapy techniques aimed at boosting [low dose rate (LDR) and high dose rate (HDR)]
详细描述
Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate, Tolerance of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated by brachytherapy anal canal to boost.
排除标准
- •Patients below age of 18 years
结局指标
主要结局
Evaluation of the efficacy of interstitial brachytherapy of the anal canal
时间窗: 1 year
Efficacy of anal canal interstitial brachytherapy evaluated by local relapse rate
Evaluation of the tolerance of interstitial brachytherapy of the anal canal
时间窗: 1 year
Tolerance of interstitial brachytherapy of the anal canal evaluated by the rate of chronic toxicities.
次要结局
- Estimation of local control(1 year)
- Estimation of disease free survival(1 year)
- Estimation of overall survival(1 year)
- Comparison of the incidence of toxicities (CTCAE v4) between the 2 groups(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Adjuvant Radiotherapy in Patients With Early Endometrial CancerEndometrial CancerPathologyRadiotherapyNCT04956601Peking University Third Hospital480
终止
1 期
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney CancerStage I Renal Cell CancerStage II Renal Cell CancerNCT04473781Jonsson Comprehensive Cancer Center2
已完成
不适用
Image Based Brachytherapy in Locally Advanced Cervical Cancers - a Randomized Controlled TrialCervical CancerNCT03005743Tata Memorial Hospital1,050
Unknown
3 期
APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast CancerBreast CancerNCT00402519University of Erlangen-Nürnberg Medical School1,300
已完成
不适用
Intraluminal brachytherapy treatment results analysis of unresectable recurrent cholangiocarcinomaNeoplasmsKCT0000738Chonbuk National University Hospital30